|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
Robert Harris, PMPS Industry Advisor, highlights the importance of patient-centricity and picks out key articles from this issue that address this topic.
|
|
|
|
|
mHealth and Smart Technology
Breathing New Life into Asthma Care
Ali Moiyed at Aerobit Health uncovers how connected devices could enhance patient compliance. With a particular focus on inhalers, he argues that this could be one way in which the pharma industry can keep up with advances in technology.
|
|
|
Optimising Inhalation Therapy
Partial to Particles
Breath-actuated mechanisms are becoming increasingly common in inhalation devices due to their beneficial impact on fine particle doses. Dr David Lewis, Alan Tweedie and Francesca Mason at Chiesi investigate their potential.
|
|
|
|
The Falsified Medicines Directive
Is Europe Ready?
As the Falsified Medicines Directive deadline looms ever closer, Christoph Krähenbühl at 3C Excellis Europe clarifies what everyone, from manufacturers to wholesalers and pharmacists, need to do to ensure that the continent is prepared.
|
|
|
|
Electronic Batch Records
Paper Chase
COPA-DATA’s Robert Harrison argues for the transition from paper-based documentation to digitised production records in a bid to improve regulatory compliance and the management of data.
|
|
|
|
Outsourcing Supply Chains
Branching Out
Developing robust supply chains while simultaneously reducing expenditure and meeting global compliance can be challenging. Henry Moran and Amy Shortman of ASC Associates share their thoughts on why turning to outsourcing could be the answer.
|
|
|
Anti-Counterfeiting Measures
Security Breach
As a result of increased globalisation, pharma firms are constantly being put under greater pressure to provide a secure end-to-end supply chain. Although a daunting challenge, Pinkerton’s Steve Ward explains how this can be achieved to ensure drug safety and mitigate the risk of large economic losses.
|
|
|
Innovative Supply Chains
New Thinking
Jan Denecker at UPS Europe discusses the significance of flexibility in the supply chain as a result of today’s shift towards increasingly complex drugs. Manufacturers and third-party logistics providers must be ready to work together to create the efficiency needed.
|
|
|
|
Advancing Patient Protection
Easy Access
Amcor’s Colin Reed and Greg Rosati investigate the vital role that packaging plays in compliance. Often seen as an inconvenient part of the supply chain, they uncover why it should be treated as more than simply fulfilling a regulatory need.
|
|
|
Child-Resistant Packaging
Open and Close
In order to develop child-resistant packaging that is also easy to use for the elderly, continuous testing is key. Stephen Wilkins at Davies Development and Testing sheds some light on the complications with regards to staying compliant.
|
|
|
Packaging Design
First Impression
Conveying important information to patients through packaging and labelling is an arduous task in the pharma industry. Essentra’s Alan Davies explains why getting it right is so important in terms of design and compliance.
|
|
|
Patient-Centred Design
Packaging for People
Dr Karel van der Waarde at Graphic Design-Research elucidates why it is necessary to consider the end user as well as legal and economic packaging requirements so that medicines can be handled safely, correctly and efficiently.
|
|
|
|
Event Preview
Join the Crowd
Valerio Del Vecchio at the PPMA Group presents an enticing look at the upcoming PPMA Show and why Birmingham is the place to be this September.
|
|
|
|
|
End of the Line
Manufacturing a Renaissance
Pharma keeps on innovating, but PMPS Industry Advisor Robert Harris asks if this is enough for the sector to stay on par with other areas.
|
|
|
|
Clinical Supply Challenges
Under Control
The manufacture and distribution of controlled drugs is tightly governed, but regulations vary around the world and tend to cause a considerable amount of complexity. PCI Clinical Services’ Rich Nelson explores why experienced supply partners are vital in this field.
|
|
|
Clinical Trial Supply
Supply and Demand
SIRO Clinpharm’s Partha Chatterjee investigates the importance of collaboration between clinical operations and clinical trial supply teams in order to achieve more effective and efficient studies.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief
Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded
generic manufacturer, says favourable conditions in the UAE are
resulting in a boom of pharmaceutical manufacturing throughout the
region. Government incentive schemes to increase domestic production,
coupled with a brand friendly environment and rising healthcare needs is
fuelling surging demand – with many new companies and plants launching
in the last two years alone.
More info >> |
|
 |
White Papers |
 |
|
Running Smarter Trials With Data-Driven Monitoring
PAREXEL
Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm. Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >> |
|
 |
Industry Events |
 |
SAPHEX 2019
23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA
SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention
Centre, Johannesburg, South Africa.
More info >> |
|
|
